People | February 28, 2026
Lupin’s Vinita Gupta honoured as CNBC Changemaker for revolutionising U.S. healthcare access
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
PEACE-3 is a strong example of how academic cooperative research can help advance progress for complex diseases such as metastatic prostate cancer
BRAFTOVI in combination with cetuximab and mFOLFOX6 had previously received accelerated approval in December 2024 based on objective response rate (ORR) results
New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
Nadda underlined that India’s policy framework is aligned with this transformation
Under the deal, Quiver will receive an undisclosed advance payment and research support
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
To support this launch, ImmunityBio has established a wholly owned subsidiary in Saudi Arabia
Merck is currently conducting approximately 80 Phase 3 studies, and the company expects more than 20 new growth drivers over next several years, almost all with blockbuster potential
The initiative, delivered in collaboration with Accenture, integrates digitally enabled operating models powered by advanced analytics and AI across the company’s procurement, manufacturing, and distribution networks
Subscribe To Our Newsletter & Stay Updated
